![(8R)-3-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol in PDB entry 3ewc, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/3ewc_entity_3_side_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>3ewc</span> contains 1 copy of <span class='highlight'>(8R)-3-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol</span>. Side view.")
![(8R)-3-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol in PDB entry 3ewc, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/3ewc_entity_3_top_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>3ewc</span> contains 1 copy of <span class='highlight'>(8R)-3-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol</span>. Top view.")
Environment details NEW
MCF 373 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.